Pliant Therapeutics, Inc. (PLRX) Tops Q3 EPS by 8c

Pliant Therapeutics, Inc. (NASDAQ: PLRX) reported Q3 EPS of ($0.70), $0.08 better than the analyst estimate of ($0.78).

For earnings history and earnings-related data on Pliant Therapeutics, Inc. (PLRX) click here.

You May Also Be Interested In

• Is Treasury selloff a major issue for stock market bulls?
• Bimergen Energy Corporation (BESS) Reports Q2 EPS of $0.22
• Yum! Brands (YUM) PT Lowered to $180 at Argus